CP10 CJC-1295 without DAC (5mg) combined with Ipamorelin (5mg) is a dual-peptide research formulation widely used in laboratory environments for investigative studies involving growth hormone releasing peptides and receptor signaling mechanisms.
CJC-1295 (No DAC) is a synthetic analog of growth hormone-releasing hormone (GHRH) studied for its extended activity in controlled research conditions. Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R1a) agonist, often used in research exploring peptide synergy, endocrine response models, and metabolic signaling pathways.
This 10mg combined vial format is intended strictly for laboratory research purposes. It is not intended for human consumption, medical use, or therapeutic application.
Key Research Focus Areas:
- Growth hormone secretagogue studies
- GHRH and GHRP receptor interaction research
- Metabolic and cellular signaling experiments
- Peptide synergy and pharmacological modeling



Reviews
There are no reviews yet.